|
gptkbp:instanceOf
|
gptkb:antibiotic
|
|
gptkbp:activeIngredient
|
gptkb:amoxicillin
gptkb:clavulanic_acid
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
J01CR02
|
|
gptkbp:brand
|
gptkb:Co-amoxiclav
gptkb:Augmentin
|
|
gptkbp:category
|
gptkb:beta-lactam_antibiotics
combination drugs
penicillin antibiotics
|
|
gptkbp:chemicalFormula
|
C16H19N3O5S (amoxicillin)
C8H9NO5 (clavulanic acid)
|
|
gptkbp:contraindication
|
penicillin allergy
|
|
gptkbp:developedBy
|
gptkb:Beecham
|
|
gptkbp:discoveredIn
|
1981
|
|
gptkbp:form
|
gptkb:tablet
oral suspension
intravenous injection
|
|
gptkbp:genericAvailable
|
true
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Augmentin
|
|
gptkbp:indication
|
gptkb:sinusitis
gptkb:pneumonia
skin infections
urinary tract infections
otitis media
dental infections
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedAs
|
GlaxoSmithKline
|
|
gptkbp:mechanismOfAction
|
inhibits bacterial cell wall synthesis
inhibits beta-lactamase enzymes
|
|
gptkbp:pregnancyCategory
|
B (US)
|
|
gptkbp:routeOfAdministration
|
oral
intravenous
|
|
gptkbp:sideEffect
|
nausea
diarrhea
allergic reaction
rash
|
|
gptkbp:usedFor
|
bacterial infections
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
|
gptkbp:bfsParent
|
gptkb:GSK
gptkb:GSK_India
|
|
gptkbp:bfsLayer
|
6
|